http://www.gotoper.com/publications/ajho/2017/2017november

November 2017


Chairman's Letter
Chairman's Letter
Michael J. Hennessy
From The Editor
From the Editor
Debu Tripathy, MD
Tumor Necrosis Receptor Agonists
TNFR Agonists: A Review of Current Biologics Targeting OX40, 4-1BB, CD27, and GITR
Elizabeth R. Sturgill, PhD, and William L. Redmond, PhD
Breast Cancer
Lumpectomy With Radiation Versus Mastectomy for Early-Stage Breast Cancer: Value-Based Treatment Considerations
Tommy Sheu, MD; Thomas A. Buchholz, MD; and Benjamin D. Smith, MD
Advanced Non-Small Cell Lung Cancer
Distilling Data Into Action: Recent Advances in the Management of Advanced Non–Small Cell Lung Cancer
Shirin Attarian, MD; Niyati Goradia, MBBS; Benjamin P. Levy, MD; and Balazs Halmos, MD, MS
Hepatocellular Carcinoma
Minimally Invasive, Image-Guided Therapy for Liver Cancer: What Every Oncologist Needs to Know
Austin-Marley Windham-Herman, BS; Julius Chapiro, MD; and Jean-François Geschwind, MD
Minimally Invasive, Image-Guided Therapy for Liver Cancer: What Every Oncologist Needs to Know
Austin-Marley Windham-Herman, BS; Julius Chapiro, MD; and Jean-François Geschwind, MD
Minimally Invasive, Image-Guided Therapy for Liver Cancer: What Every Oncologist Needs to Know
Bladder Cancer
GIST in Pregnancy: The Role of Circulating Tumor DNA to Define the Assessment of Risk of Rapid Progression and Response to Imatinib
Vaia Florou, MD; Jeremy Ramdial, MD; and Jonathan C. Trent, MD, PhD
GIST in Pregnancy: The Role of Circulating Tumor DNA to Define the Assessment of Risk of Rapid Progression and Response to Imatinib
CME
Assessing Current and Future Roles for Immuno-Oncology Strategies in Bladder Cancer
Arjun V. Balar, MD